News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Higher Deductibles and Co-Insurance Costs Squeezing Healthcare Consumers’ Wallets; A Reasons for Clinical Labs to Make Lab Test Prices Easy to See

Two new studies show patients are being increasingly burdened with a greater share of healthcare costs, which requires providers, including medical labs, to collect more money from patients at time of service

Although wage increases remain stagnant, consumers now pay a steadily increasing share of their healthcare costs. That’s because of rising deductibles, co-insurance, and other out-of-pocket costs. Not only will this cost-sharing trend continue to stretch patients’ budgets, it also will apply more pressure on clinical laboratories and pathology groups to increase price transparency for patients.

A recent study at the University of Michigan (UM), published in the Journal of the American Medical Association (JAMA), highlighted the growth in out-of-pocket insurance costs for hospitalized patients. For the average consumer with private health insurance, costs rose from $738 in 2009 to $1,013 in 2013—a 37% increase. During that same 4-year period, overall healthcare spending grew at 2.9% per year and health insurance premiums went up 5.1% annually.

Two types of health insurance plan charges were responsible for the biggest change in out-of-pocket spending: deductibles and co-insurance. During the same period, deductibles rose by 86%! Co-insurance costs increased 33% over the same period. Co-payments (a flat fee) were used in fewer hospitalizations. (more…)

National Data Points to Major Victory in War on Hypertension

Improved patient health status for controlling high blood pressure augurs well for clinical laboratory testing industry

There’s a big win in the decade-long national effort to reduce high blood pressure in a large number of Americans. Researchers and health policy experts are hailing this accomplishment as proof that patients, physicians, and payers can work together and measurably improve the state of the nation’s health.

For pathologists and clinical laboratory managers, this is a significant development, because medical laboratory testing plays an essential role in diagnosing disease and monitoring the patient’s progress. Therefore, evidence that a national effort on different chronic diseases—such as high blood pressure—can measurably improve the state of health of large numbers of patients helps affirm the value of clinical lab tests in reaching these goals. (more…)

;